Upregulation of PAWR by small activating RNAs induces cell apoptosis in human prostate cancer cells

Yang,Kai; Shen,Jie; Chen,Shan-Wen; Qin,Jie; Zheng,Xiang-Yi; Xie,Li-Ping

doi:10.3892/or.2016.4582

Upregulation of PAWR by small activating RNAs induces cell apoptosis in human prostate cancer cells

Authors:
- Kai Yang
- Jie Shen
- Shan-Wen Chen
- Jie Qin
- Xiang-Yi Zheng
- Li-Ping Xie
View Affiliations

Affiliations: Department of Urology, The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China, Department of Pharmacy, Traditional Chinese Medical Hospital of Zhejiang Province, Hangzhou, Zhejiang 310006, P.R. China
Published online on: January 21, 2016 https://doi.org/10.3892/or.2016.4582
Pages: 2487-2493

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

RNA activation (RNAa) is a promising discovery whereby expression of a particular gene can be induced by targeting its promoter using small double-stranded RNAs (dsRNAs) also termed small activating RNAs (saRNAs). We previously reported that several small dsRNAs targeting the PRKC apoptosis WT1 regulator (PAWR) promoter can upregulate PAWR gene expression effectively in human cancer cells. The present study was conducted to evaluate the antitumor potential of PAWR gene induction by these saRNAs in prostate cancer cells. Promisingly, we found that upregulation of PAWR by saRNA inhibited the growth of prostate cancer cells by inducing cell apoptosis which was related to inactivation of the NF-κB and Akt pathways. The decreased anti‑apoptotic protein Bcl-2 and activation of the caspase cascade and poly(ADP-ribose) polymerase (PARP) also supported the efficacy of the treatment. Overall, these data suggest that activation of PAWR by saRNA may have a therapeutic benefit for prostate and other types of cancer.

View Figures

View References

1	Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
2	Lares MR, Rossi JJ and Ouellet DL: RNAi and small interfering RNAs in human disease therapeutic applications. Trends Biotechnol. 28:570–579. 2010. View Article : Google Scholar : PubMed/NCBI
3	Castanotto D and Rossi JJ: The promises and pitfalls of RNA-interference-based therapeutics. Nature. 457:426–433. 2009. View Article : Google Scholar : PubMed/NCBI
4	Tiemann K and Rossi JJ: RNAi-based therapeutics-current status, challenges and prospects. EMBO Mol Med. 1:142–151. 2009. View Article : Google Scholar
5	Li LC, Okino ST, Zhao H, Pookot D, Place RF, Urakami S, Enokida H and Dahiya R: Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci USA. 103:17337–17342. 2006. View Article : Google Scholar : PubMed/NCBI
6	Janowski BA, Younger ST, Hardy DB, Ram R, Huffman KE and Corey DR: Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat Chem Biol. 3:166–173. 2007. View Article : Google Scholar : PubMed/NCBI
7	Place RF, Li LC, Pookot D, Noonan EJ and Dahiya R: MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci USA. 105:1608–1613. 2008. View Article : Google Scholar : PubMed/NCBI
8	Turunen MP, Lehtola T, Heinonen SE, Assefa GS, Korpisalo P, Girnary R, Glass CK, Väisänen S and Ylä-Herttuala S: Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism: A novel example of epigenetherapy. Circ Res. 105:604–609. 2009. View Article : Google Scholar : PubMed/NCBI
9	Huang V, Qin Y, Wang J, Wang X, Place RF, Lin G, Lue TF and Li LC: RNAa is conserved in mammalian cells. PLoS One. 5:e88482010. View Article : Google Scholar : PubMed/NCBI
10	Wang J, Place RF, Huang V, Wang X, Noonan EJ, Magyar CE, Huang J and Li LC: Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Res. 70:10182–10191. 2010. View Article : Google Scholar : PubMed/NCBI
11	Matsui M, Sakurai F, Elbashir S, Foster DJ, Manoharan M and Corey DR: Activation of LDL receptor expression by small RNAs complementary to a noncoding transcript that overlaps the LDLR promoter. Chem Biol. 17:1344–1355. 2010. View Article : Google Scholar : PubMed/NCBI
12	Wang X, Wang J, Huang V, Place RF and Li LC: Induction of NANOG expression by targeting promoter sequence with small activating RNA antagonizes retinoic acid-induced differentiation. Biochem J. 443:821–828. 2012. View Article : Google Scholar : PubMed/NCBI
13	Wang T, Li M, Yuan H, Zhan Y, Xu H, Wang S, Yang W, Liu J, Ye Z and Li LC: saRNA guided iNOS up-regulation improves erectile function of diabetic rats. J Urol. 190:790–798. 2013. View Article : Google Scholar : PubMed/NCBI
14	Yang K, Shen J, Xie YQ, Lin YW, Qin J, Mao QQ, Zheng XY and Xie LP: Promoter-targeted double-stranded small RNAs activate PAWR gene expression in human cancer cells. Int J Biochem Cell Biol. 45:1338–1346. 2013. View Article : Google Scholar : PubMed/NCBI
15	Chen Z, Place RF, Jia ZJ, Pookot D, Dahiya R and Li LC: Antitumor effect of dsRNA-induced p21^WAF1/CIP1 gene activation in human bladder cancer cells. Mol Cancer Ther. 7:698–703. 2008. View Article : Google Scholar : PubMed/NCBI
16	Yang K, Zheng XY, Qin J, Wang YB, Bai Y, Mao QQ, Wan Q, Wu ZM and Xie LP: Up-regulation of p21^WAF1/Cip1 by saRNA induces G1-phase arrest and apoptosis in T24 human bladder cancer cells. Cancer Lett. 265:206–214. 2008. View Article : Google Scholar : PubMed/NCBI
17	Whitson JM, Noonan EJ, Pookot D, Place RF and Dahiya R: Double stranded-RNA-mediated activation of P21 gene induced apoptosis and cell cycle arrest in renal cell carcinoma. Int J Cancer. 125:446–452. 2009. View Article : Google Scholar : PubMed/NCBI
18	Wei J, Zhao J, Long M, Han Y, Wang X, Lin F, Ren J, He T and Zhang H: p21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell. BMC Cancer. 10:6322010. View Article : Google Scholar : PubMed/NCBI
19	Place RF, Wang J, Noonan EJ, Meyers R, Manoharan M, Charisse K, Duncan R, Huang V, Wang X and Li LC: Formulation of small activating RNA into lipidoid nanoparticles inhibits xenograft prostate tumor growth by inducing p21 expression. Mol Ther Nucleic Acids. 1:e152012. View Article : Google Scholar :
20	Kang MR, Yang G, Place RF, Charisse K, Epstein-Barash H, Manoharan M and Li LC: Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth. Cancer Res. 72:5069–5079. 2012. View Article : Google Scholar : PubMed/NCBI
21	Johnstone RW, Tommerup N, Hansen C, Vissing H and Shi Y: Mapping of the human PAWR (par-4) gene to chromosome 12q21. Genomics. 53:241–243. 1998. View Article : Google Scholar : PubMed/NCBI
22	Sells SF, Wood DP Jr, Joshi-Barve SS, Muthukumar S, Jacob RJ, Crist SA, Humphreys S and Rangnekar VM: Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells. Cell Growth Differ. 5:457–466. 1994.PubMed/NCBI
23	Chakraborty M, Qiu SG, Vasudevan KM and Rangnekar VM: Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression. Cancer Res. 61:7255–7263. 2001.PubMed/NCBI
24	Gurumurthy S, Goswami A, Vasudevan KM and Rangnekar VM: Phosphorylation of Par-4 by protein kinase A is critical for apoptosis. Mol Cell Biol. 25:1146–1161. 2005. View Article : Google Scholar : PubMed/NCBI
25	Goswami A, Burikhanov R, de Thonel A, Fujita N, Goswami M, Zhao Y, Eriksson JE, Tsuruo T and Rangnekar VM: Binding and phosphorylation of par-4 by akt is essential for cancer cell survival. Mol Cell. 20:33–44. 2005. View Article : Google Scholar : PubMed/NCBI
26	El-Guendy N, Zhao Y, Gurumurthy S, Burikhanov R and Rangnekar VM: Identification of a unique core domain of par-4 sufficient for selective apoptosis induction in cancer cells. Mol Cell Biol. 23:5516–5525. 2003. View Article : Google Scholar : PubMed/NCBI
27	Qiu G, Ahmed M, Sells SF, Mohiuddin M, Weinstein MH and Rangnekar VM: Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4. Oncogene. 18:623–631. 1999. View Article : Google Scholar : PubMed/NCBI
28	Cheema SK, Mishra SK, Rangnekar VM, Tari AM, Kumar R and Lopez-Berestein G: Par-4 transcriptionally regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter. J Biol Chem. 278:19995–20005. 2003. View Article : Google Scholar : PubMed/NCBI
29	Diaz-Meco MT and Abu-Baker S: The Par-4/PTEN connection in tumor suppression. Cell Cycle. 8:2518–2522. 2009. View Article : Google Scholar : PubMed/NCBI
30	Goswami A, Ranganathan P and Rangnekar VM: The phos-phoinositide 3-kinase/Akt1/Par-4 axis: A cancer-selective therapeutic target. Cancer Res. 66:2889–2892. 2006. View Article : Google Scholar : PubMed/NCBI
31	Nalca A, Qiu SG, El-Guendy N, Krishnan S and Rangnekar VM: Oncogenic Ras sensitizes cells to apoptosis by Par-4. J Biol Chem. 274:29976–29983. 1999. View Article : Google Scholar : PubMed/NCBI
32	Diaz-Meco MT, Lallena MJ, Monjas A, Frutos S and Moscat J: Inactivation of the inhibitory kappaB protein kinase/nuclear factor kappaB pathway by Par-4 expression potentiates tumor necrosis factor alpha-induced apoptosis. J Biol Chem. 274:19606–19612. 1999. View Article : Google Scholar : PubMed/NCBI
33	Manning BD and Cantley LC: AKT/PKB signaling: Navigating downstream. Cell. 129:1261–1274. 2007. View Article : Google Scholar : PubMed/NCBI
34	Malik SN, Brattain M, Ghosh PM, Troyer DA, Prihoda T, Bedolla R and Kreisberg JI: Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer. Clin Cancer Res. 8:1168–1171. 2002.PubMed/NCBI
35	Joshi J, Fernandez-Marcos PJ, Galvez A, Amanchy R, Linares JF, Duran A, Pathrose P, Leitges M, Cañamero M, Collado M, et al: Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesis. EMBO J. 27:2181–2193. 2008. View Article : Google Scholar : PubMed/NCBI
36	Barkett M and Gilmore TD: Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene. 18:6910–6924. 1999. View Article : Google Scholar : PubMed/NCBI
37	Salvesen GS and Dixit VM: Caspase activation: The induced-proximity model. Proc Natl Acad Sci USA. 96:10964–10967. 1999. View Article : Google Scholar : PubMed/NCBI
38	Ivana Scovassi A and Diederich M: Modulation of poly(ADP-ribo-sylation) in apoptotic cells. Biochem Pharmacol. 68:1041–1047. 2004. View Article : Google Scholar : PubMed/NCBI